Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of TwHF in HIV Patients With Poor Immune Responses

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Continuous antiretroviral therapy \> 18 months, and consistent HIV-RNA\< 40 copies/mL more than 12 months;~* 18-65 years old;~* Male or female;~* Good adherence and promise to follow-up;~* Inform Consent signed;~* CD4 T cells less than 300/ul .~Exclusion Criteria:~* Active opportunistic infection (not stable within 4 weeks 2 weeks ) or AIDS-related carcinoma;~* Hemoglobin (HGB) \< 9 g/dl, white blood cell (WBC) \< 2000/ul, granulin (GRN) \< 1000 /ul, platelet (PLT) \< 75000 /ul, Cr \>1.5x ULN, ALT or AST or alkaline phosphatase (ALP) \>3x upper limit of normal (ULN), total bilirubin (TBIL) \>2x ULN, creatine kinase (CK) \> 2x ULN;~* Pregnant or breastfeeding woman or woman with pregnancy plan;~* Active drug-user;~* Severe neurological defects;~* Active alcohol abuse;~* Severe gastrointestinal ulcer .~* End-stage disease such as cirrhosis, chronic obstructive pulmonary disease, congestive heart failure, recent myocardial ischemia,tumor, etc Those who are undertaking steroids, immunomodulator, anti-inflammatory agents

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- TwHF extract + cART (Type: EXPERIMENTAL): Use Tripterygium Wilfordii Hook F extract (TwHF extract) and continue current cART regimen
- cART control (Type: OTHER): Continue current cART regimen

Based on this trial design, predict the completion outcome and termination type (if applicable).